KBC Securities
Established in 1991, KBC Securities is a Brussels-based firm offering corporate finance services. It provides advisory services in equity capital markets, mergers & acquisitions, syndication, debt markets, project finance, and initial public offerings.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
2 past transactions
PanTera
Debt Financing in 2024
PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.
Ablynx
Post in 2014
Ablynx is a biopharmaceutical company focused on discovering and developing Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These Nanobodies are designed to treat serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. The company currently has around 25 projects in its pipeline, with five Nanobodies in clinical development. Ablynx's products aim to combine the advantages of conventional antibodies and small chemical molecules, offering patients innovative therapeutic options that can significantly impact society.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.